BSH SIG podcasts

Episode 3: Management of Waldenström macroglobulinaemia (01/2022) – Length: 30:15

Dr Shirley D’Sa discusses the management of Waldenström macroglobulinaemia (WM).
Dr D’Sa is a haematologist and associate professor at University College London Hospitals NHS Foundation Trust (UCLH), a busy academic centre in central London, where she also completed her specialist training in haematology.
She specialises in the management of patients with Immunoglobulin M (IgM) related conditions and paraproteinaemic neuropathies.
She is the clinical lead for the UCLH Centre for WM and Related Disorders and haematological lead in the Joint Neurohaematology Service alongside the neurology lead, Professor Michael Lunn, at the National Hospital for Neurology, Queen Square, London.
Dr D’Sa is a co-trustee with patients and colleagues in the UK-registered charity, WMUK. She is the Chief Investigator for the Rory Morrison Registry project for WM and associated conditions, which has more than 1,200 patients registered from several centres across the UK. And a member of the UK Medical Advisory Panel of Lymphoma Action.
Dr D’Sa is a CI/PI in several clinical trials in WM and cold agglutinin disease (CAD) and is a committee member of the International Workshops on WM and the BSH Guidelines group.
She is a supervisor to successive research fellows in the field of Waldenström and paraproteinaemic neuropathies, as well as haematology specialist trainees and undergraduates at the University College London (UCL) Medical School.

Episode 2: Clinical management of mantle cell lymphoma (10/2021) – Length: 30:11

Dr Rory McCulloch discusses the clinical management of mantle cell lymphoma (MCL), including indolent MCL, upfront management in younger patients, challenges of aggressive blastoid disease and how new therapies may shape future treatment algorithms.
Dr McCulloch is a consultant haematologist at Gloucestershire Hospitals NHS Foundation Trust and recently worked as a Lymphoma Clinical Research Fellow under Professor Simon Rule at Plymouth University.
He was vice-chair of the trainee-led research network HaemSTAR and is a BSH Lymphoma Special Interest Group member.

Episode 1: Management of patients with early, unfavourable Hodgkin's lymphoma (07/2021) – Length: 22:30

Dr Wendy Osborne discusses an approach to the management of patients with early, unfavourable Hodgkin's lymphoma, focusing on the current evidence, the role of positron emission tomography (PET) and the challenges faced by this subgroup of patients.
Dr Osborne is a consultant haematologist at Newcastle upon Tyne Hospitals NHS Foundation Trust. She has a specialist interest in the field of lymphoma, is a member of the National Cancer Research Institute (NCRI) clinical subgroups looking at high-grade Hodgkin's and T cell lymphomas, and is the chair of the BSH Lymphoma Special Interest Group.